查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1945422

2026年全球静脉输液药物输送装置市场报告

Intravenous Fluid Transfer Drug Devices Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，静脉输液给药装置市场发展迅猛，预计到 2026 年将达到 83.5 亿美元，2025 年的复合年增长率为 6.3%，而 2025 年的复合年增长率为 78.5 亿美元。过去几年成长要素包括对传统输液装置的依赖、医院和临床手术数量的增加、智能输液装置的供应有限、人们对输液疗法益处的认识不断提高以及 PVC 输液袋的采用。

预计未来几年，静脉输液给药装置市场将维持强劲成长，2030年市场规模将达到105.5亿美元，复合年增长率（CAGR）为6.0%。预测期内的成长要素包括智慧输液帮浦的技术进步、预填充和多腔输液袋需求的成长、肿瘤科和神经科应用领域的拓展、居家医疗和门诊输液的成长，以及更严格的监管和品质标准。预测期内的主要趋势包括智慧型输液装置和输液帮浦的日益普及、预填充和多腔输液袋使用量的增加、无针连接器和安全型输液器需求的增长、慢性病和重症监护环境中静脉输液疗法的扩展，以及对无菌性、精确性和流量控制的日益重视。

住院率上升是静脉输液和药物传输设备市场扩张的关键驱动因素。这一趋势与人口老化、慢性病、诊断能力的提高、医疗保健覆盖范围的扩大以及文明病密切相关。静脉输液和药物输送设备可确保将液体和药物精准、可控地直接输送到住院患者的血液中，从而支持有效的治疗和保障患者安全。例如，根据英国政府机构GOV.UK的数据，截至2023年3月，英格兰的COVID-19住院率略有上升，达到每10万人10.62例，而加护病房（ICU）和高剂量治疗病房（HDU）的入院率仍然较低。因此，住院率的上升正在推动整个静脉输液和药物输送设备市场的成长。

静脉输液药物输送设备市场的主要企业正在开发模组化、综合性的输液系统，这些系统具备自动识别等功能，旨在提高输液准确性、增强患者安全性并简化输液和药物管理流程。自动识别技术利用条码扫描和RFID系统自动检验药物并将其配对到正确的患者。例如，2023年7月，美国医疗设备製造商贝克顿·迪金森公司（Becton Dickinson）的改良型BD Alaris输液系统获得了FDA 510(k)许可。该系统配备了升级的照护现场硬件，包括大容量输液泵、注射式帮浦、患者自控镇痛泵、呼吸监测装置和自动识别模组。此外，该系统还整合了具有增强的网路安全性和互通性的先进软体，能够与电子健康记录系统无缝集成，并支援连线健诊医疗的交付。

目录

第一章执行摘要

第二章 市场特征

  • 市场定义和范围
  • 市场区隔
  • 主要产品和服务概述
  • 全球静脉输液药物输送装置市场：吸引力评分及分析
  • 成长潜力分析、竞争评估、策略契合度评估、风险状况评估

第三章 市场供应链分析

  • 供应链与生态系概述
  • 主要原料、资源和供应商清单
  • 主要经销商和通路合作伙伴名单
  • 主要最终用户列表

第四章 全球市场趋势与策略

  • 关键技术和未来趋势
    • 工业4.0和智慧製造
    • 数位化、云端运算、巨量资料、网路安全
    • 生物技术、基因组学和精准医学
    • 物联网、智慧基础设施和互联生态系统
    • 自主系统、机器人与智慧运输
  • 主要趋势
    • 智慧型输液设备和帮浦的普及率不断提高
    • 预填充和多腔输液袋的使用增加
    • 对无针连接器和安全型输液装置的需求不断增长
    • 在慢性病和重症监护环境中推广静脉输液疗法
    • 更重视无菌性、精确性和流量控制

第五章 终端用户产业市场分析

  • 医院
  • 专科诊所
  • 居家医疗保健服务提供者
  • 门诊治疗中心
  • 製药和生物技术研究设施

第六章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税的影响、关税战和贸易保护主义对供应链的影响，以及新冠疫情对市场的影响

第七章 全球策略分析架构、目前市场规模、市场对比及成长率分析

  • 全球静脉输液药物输送装置市场：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 全球静脉输液药物输送装置市场规模、对比及成长率分析
  • 全球静脉输液药物输送装置市场表现：规模与成长，2020-2025年
  • 全球静脉输液输液器材市场预测：规模与成长，2025-2030年，2035年预测

第八章 全球潜在市场规模（TAM）

第九章 市场细分

  • 按类型
  • 输液袋、输液装置及其他类型
  • 透过使用
  • 自体免疫疾病、血液系统疾病、心血管疾病、神经系统疾病、肿瘤及其他适应症
  • 按最终用户类别
  • 医院、专科诊所和其他终端用途区域
  • 按类型细分：输液袋
  • PVC输液袋、非PVC输液袋、预填充输液袋、多腔输液袋、输液袋
  • 按类型细分：输液装置
  • 输液帮浦、注射式帮浦、携带式输液帮浦、重力输液装置、智慧型输液装置
  • 按类型细分：其他类型
  • 输液器及配件、静脉导管、无针接头、流量调节器、加压输液装置

第十章 区域与国家分析

  • 全球静脉输液药物输送装置市场：区域分析、预测与趋势，2020-2025年、2025-2030年预测、2035年预测
  • 全球静脉输液输注药物装置市场：国家/地区、市场表现及预测，2020-2025年、2025-2030年预测、2035年预测

第十一章 亚太市场

第十二章：中国市场

第十三章 印度市场

第十四章 日本市场

第十五章：澳洲市场

第十六章 印尼市场

第十七章 韩国市场

第十八章 台湾市场

第十九章 东南亚市场

第二十章：西欧市场

第21章英国市场

第22章 德国市场

第23章：法国市场

第24章：义大利市场

第25章：西班牙市场

第26章 东欧市场

第27章：俄罗斯市场

第28章 北美市场

第29章：美国市场

第30章：加拿大市场

第31章 南美洲市场

第32章：巴西市场

第33章 中东市场

第34章：非洲市场

第35章 市场监理与投资环境

第三十六章：竞争格局与公司概况

  • 静脉输液药物输送装置市场：竞争格局及市场份额（2024年）
  • 静脉输液药物输送装置市场：公司估值矩阵
  • 静脉输液药物输送装置市场：公司概况
    • Cardinal Health Inc.
    • Medtronic plc
    • Becton Dickinson and Company
    • Baxter International Inc.
    • B Braun Holding GmbH Co KG

第37章：其他领先和创新企业

  • Fresenius Kabi AG, Nipro Corporation, West Pharmaceutical Services Inc., ICU Medical Inc., Merit Medical Systems Inc., Vygon SAS, AngioDynamics Inc., Elcam Medical Inc., InfuSystem Holdings Inc., CODAN US Corporation, Arcomed AG, Terumo Corporation, Smiths Medical, IRadimed Corporation, Micrel Medical Devices SA

第38章 全球市场竞争基准分析与仪錶板

第39章 重大併购

第四十章：高潜力市场国家、细分市场与策略

  • 2030年静脉输液药物输送装置市场：提供新机会的国家
  • 2030年静脉输液药物输送装置市场：提供新机会的细分市场
  • 2030年静脉输液药物输送装置市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第41章附录

简介目录
Product Code: ME5MIFTD01_G26Q1

Intravenous fluid transfer drug devices deliver medications and fluids directly into the bloodstream through an IV line while maintaining sterility and preventing contamination, supporting efficient and controlled treatment in critical care settings.

The main product categories in the intravenous fluid transfer drug devices market include infusion bags, infusion devices, and others. Infusion bags are flexible, sterile containers designed to store and deliver fluids, medications, or nutrients directly into a patient's bloodstream through an intravenous (IV) line. The applications include autoimmune disorders, blood-related conditions, cardiovascular disorders, neurological conditions, oncology treatments, and others, and the end users include hospitals, specialized clinics, and others.

Tariffs are impacting the intravenous fluid transfer drug devices market by increasing costs for imported infusion bags, smart infusion pumps, and needleless connectors. Segments such as multi-chamber infusion bags and smart infusion devices are most affected, particularly in Asia-Pacific regions including China and India. The tariffs have led to higher production costs and supply chain disruptions. On the positive side, they are encouraging local manufacturing, material innovation, and investment in domestic production capabilities, which may enhance long-term market resilience.

The intravenous fluid transfer drug devices market research report is one of a series of new reports from The Business Research Company that provides intravenous fluid transfer drug devices market statistics, including intravenous fluid transfer drug devices industry global market size, regional shares, competitors with a intravenous fluid transfer drug devices market share, detailed intravenous fluid transfer drug devices market segments, market trends and opportunities, and any further data you may need to thrive in the intravenous fluid transfer drug devices industry. This intravenous fluid transfer drug devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The intravenous fluid transfer drug devices market size has grown strongly in recent years. It will grow from $7.85 billion in 2025 to $8.35 billion in 2026 at a compound annual growth rate (CAGR) of 6.3%. The growth in the historic period can be attributed to reliance on conventional iv sets, increasing hospital and clinical procedures, limited availability of smart infusion devices, growing awareness of iv therapy benefits, adoption of pvc infusion bags.

The intravenous fluid transfer drug devices market size is expected to see strong growth in the next few years. It will grow to $10.55 billion in 2030 at a compound annual growth rate (CAGR) of 6.0%. The growth in the forecast period can be attributed to technological advancements in smart infusion pumps, rising demand for pre-filled and multi-chamber infusion bags, increasing applications in oncology and neurology, growth in home healthcare and ambulatory infusion, stricter regulatory and quality standards. Major trends in the forecast period include rising adoption of smart infusion devices and pumps, increasing use of pre-filled and multi-chamber infusion bags, growing demand for needleless connectors and safety iv sets, expansion of iv therapy across chronic and critical care treatments, enhanced focus on sterility, accuracy, and flow control.

The rising hospitalization rate is increasingly supporting the expansion of the intravenous fluid transfer drug device market going forward. Higher hospitalization rates are associated with aging populations, chronic diseases, improved diagnostic capabilities, broader healthcare access, and lifestyle-related health conditions. Intravenous fluid transfer drug devices ensure accurate and controlled delivery of fluids and medications directly into the bloodstream of hospitalized patients, supporting effective treatment and patient safety. For example, in March 2023, according to GOV.UK, a UK-based government organization, COVID-19 hospital admission rates in England increased slightly to 10.62 per 100,000 in 2023, while ICU and HDU admissions remained low. Consequently, rising hospitalization rates are reinforcing growth across the intravenous fluid transfer drug device market.

Leading companies in the intravenous fluid transfer drug device market are developing modular and comprehensive infusion systems with features such as auto-identification to improve accuracy, enhance patient safety, and streamline fluid and medication administration. Auto-identification technology automatically verifies and matches medications to the correct patient using barcode scanning or RFID systems. For example, in July 2023, Becton, Dickinson, and Company, a US-based medical device company, received FDA 510(k) clearance for its updated BD Alaris Infusion System. The system includes upgraded hardware for the Point-of-Care Unit, covering large-volume pumps, syringe pumps, patient-controlled analgesia pumps, respiratory monitoring, and auto-identification modules. It also introduces advanced software with improved cybersecurity and interoperability, allowing seamless integration with electronic medical record systems and supporting connected healthcare delivery.

In May 2024, Nordson Corporation, a US-based precision technology company, acquired Atrion Corporation for an undisclosed amount. Through this acquisition, Nordson Corporation aims to expand and strengthen its medical portfolio by integrating Atrion's advanced infusion and cardiovascular technologies. Atrion Corporation is a US-based technology company specializing in components and devices for intravenous fluid transfer and drug delivery.

Major companies operating in the intravenous fluid transfer drug devices market are Cardinal Health Inc., Medtronic plc, Becton Dickinson and Company, Baxter International Inc., B Braun Holding GmbH Co KG, Fresenius Kabi AG, Nipro Corporation, West Pharmaceutical Services Inc., ICU Medical Inc., Merit Medical Systems Inc., Vygon SAS, AngioDynamics Inc., Elcam Medical Inc., InfuSystem Holdings Inc., CODAN US Corporation, Arcomed AG, Terumo Corporation, Smiths Medical, IRadimed Corporation, Micrel Medical Devices SA, Boston Scientific Corporation, AdvaCare Pharma, Eitan Medical, Ypsomed Holding AG

North America was the largest region in the intravenous fluid transfer drug devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the intravenous fluid transfer drug devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the intravenous fluid transfer drug devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The intravenous fluid transfer drug devices market consists of sales of infusion pumps, IV bags, tubing sets, connectors, catheters, needles, flow regulators, and syringes. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Intravenous Fluid Transfer Drug Devices Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses intravenous fluid transfer drug devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for intravenous fluid transfer drug devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The intravenous fluid transfer drug devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Type: Infusion Bags; Infusion Devices; Other Types
  • 2) By Application: Autoimmune Diseases; Blood Disorders; Cardiovascular Disorders; Neurology; Oncology; Other Applications
  • 3) By End-Use Sector: Hospitals; Specialized Clinics; Other End-Use Sectors
  • Subsegments:
  • 1) By Infusion Bags: PVC Infusion Bags; Non-PVC Infusion Bags; Pre-Filled Infusion Bags; Multi-Chamber Infusion Bags; IV Fluid Administration Bags
  • 2) By Infusion Devices: Infusion Pumps; Syringe Pumps; Ambulatory Infusion Pumps; Gravity Infusion Devices; Smart Infusion Devices
  • 3) By Other Types: IV Sets And Accessories; IV Catheters; Needleless Connectors; Flow Regulators; Pressure Infusion Devices
  • Companies Mentioned: Cardinal Health Inc.; Medtronic plc; Becton Dickinson and Company; Baxter International Inc.; B Braun Holding GmbH Co KG; Fresenius Kabi AG; Nipro Corporation; West Pharmaceutical Services Inc.; ICU Medical Inc.; Merit Medical Systems Inc.; Vygon SAS; AngioDynamics Inc.; Elcam Medical Inc.; InfuSystem Holdings Inc.; CODAN US Corporation; Arcomed AG; Terumo Corporation; Smiths Medical; IRadimed Corporation; Micrel Medical Devices SA; Boston Scientific Corporation; AdvaCare Pharma; Eitan Medical; Ypsomed Holding AG
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Intravenous Fluid Transfer Drug Devices Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Intravenous Fluid Transfer Drug Devices Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Intravenous Fluid Transfer Drug Devices Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Intravenous Fluid Transfer Drug Devices Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Industry 4.0 & Intelligent Manufacturing
    • 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.3 Biotechnology, Genomics & Precision Medicine
    • 4.1.4 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
    • 4.1.5 Autonomous Systems, Robotics & Smart Mobility
  • 4.2. Major Trends
    • 4.2.1 Rising Adoption Of Smart Infusion Devices And Pumps
    • 4.2.2 Increasing Use Of Pre-Filled And Multi-Chamber Infusion Bags
    • 4.2.3 Growing Demand For Needleless Connectors And Safety Iv Sets
    • 4.2.4 Expansion Of Iv Therapy Across Chronic And Critical Care Treatments
    • 4.2.5 Enhanced Focus On Sterility, Accuracy, And Flow Control

5. Intravenous Fluid Transfer Drug Devices Market Analysis Of End Use Industries

  • 5.1 Hospitals
  • 5.2 Specialized Clinics
  • 5.3 Home Healthcare Providers
  • 5.4 Ambulatory Care Centers
  • 5.5 Pharmaceutical And Biotechnology Research Facilities

6. Intravenous Fluid Transfer Drug Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Intravenous Fluid Transfer Drug Devices Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Intravenous Fluid Transfer Drug Devices PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Intravenous Fluid Transfer Drug Devices Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Intravenous Fluid Transfer Drug Devices Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Intravenous Fluid Transfer Drug Devices Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Intravenous Fluid Transfer Drug Devices Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Intravenous Fluid Transfer Drug Devices Market Segmentation

  • 9.1. Global Intravenous Fluid Transfer Drug Devices Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Infusion Bags, Infusion Devices, Other Types
  • 9.2. Global Intravenous Fluid Transfer Drug Devices Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Autoimmune Diseases, Blood Disorders, Cardiovascular Disorders, Neurology, Oncology, Other Applications
  • 9.3. Global Intravenous Fluid Transfer Drug Devices Market, Segmentation By End-Use Sector, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals, Specialized Clinics, Other End-Use Sectors
  • 9.4. Global Intravenous Fluid Transfer Drug Devices Market, Sub-Segmentation Of Infusion Bags, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • PVC Infusion Bags, Non-PVC Infusion Bags, Pre-Filled Infusion Bags, Multi-Chamber Infusion Bags, IV Fluid Administration Bags
  • 9.5. Global Intravenous Fluid Transfer Drug Devices Market, Sub-Segmentation Of Infusion Devices, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Infusion Pumps, Syringe Pumps, Ambulatory Infusion Pumps, Gravity Infusion Devices, Smart Infusion Devices
  • 9.6. Global Intravenous Fluid Transfer Drug Devices Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • IV Sets And Accessories, IV Catheters, Needleless Connectors, Flow Regulators, Pressure Infusion Devices

10. Intravenous Fluid Transfer Drug Devices Market Regional And Country Analysis

  • 10.1. Global Intravenous Fluid Transfer Drug Devices Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Intravenous Fluid Transfer Drug Devices Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Intravenous Fluid Transfer Drug Devices Market

  • 11.1. Asia-Pacific Intravenous Fluid Transfer Drug Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Intravenous Fluid Transfer Drug Devices Market, Segmentation By Type, Segmentation By Application, Segmentation By End-Use Sector, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Intravenous Fluid Transfer Drug Devices Market

  • 12.1. China Intravenous Fluid Transfer Drug Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Intravenous Fluid Transfer Drug Devices Market, Segmentation By Type, Segmentation By Application, Segmentation By End-Use Sector, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Intravenous Fluid Transfer Drug Devices Market

  • 13.1. India Intravenous Fluid Transfer Drug Devices Market, Segmentation By Type, Segmentation By Application, Segmentation By End-Use Sector, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Intravenous Fluid Transfer Drug Devices Market

  • 14.1. Japan Intravenous Fluid Transfer Drug Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Intravenous Fluid Transfer Drug Devices Market, Segmentation By Type, Segmentation By Application, Segmentation By End-Use Sector, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Intravenous Fluid Transfer Drug Devices Market

  • 15.1. Australia Intravenous Fluid Transfer Drug Devices Market, Segmentation By Type, Segmentation By Application, Segmentation By End-Use Sector, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Intravenous Fluid Transfer Drug Devices Market

  • 16.1. Indonesia Intravenous Fluid Transfer Drug Devices Market, Segmentation By Type, Segmentation By Application, Segmentation By End-Use Sector, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Intravenous Fluid Transfer Drug Devices Market

  • 17.1. South Korea Intravenous Fluid Transfer Drug Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Intravenous Fluid Transfer Drug Devices Market, Segmentation By Type, Segmentation By Application, Segmentation By End-Use Sector, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Intravenous Fluid Transfer Drug Devices Market

  • 18.1. Taiwan Intravenous Fluid Transfer Drug Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Intravenous Fluid Transfer Drug Devices Market, Segmentation By Type, Segmentation By Application, Segmentation By End-Use Sector, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Intravenous Fluid Transfer Drug Devices Market

  • 19.1. South East Asia Intravenous Fluid Transfer Drug Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Intravenous Fluid Transfer Drug Devices Market, Segmentation By Type, Segmentation By Application, Segmentation By End-Use Sector, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Intravenous Fluid Transfer Drug Devices Market

  • 20.1. Western Europe Intravenous Fluid Transfer Drug Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Intravenous Fluid Transfer Drug Devices Market, Segmentation By Type, Segmentation By Application, Segmentation By End-Use Sector, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Intravenous Fluid Transfer Drug Devices Market

  • 21.1. UK Intravenous Fluid Transfer Drug Devices Market, Segmentation By Type, Segmentation By Application, Segmentation By End-Use Sector, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Intravenous Fluid Transfer Drug Devices Market

  • 22.1. Germany Intravenous Fluid Transfer Drug Devices Market, Segmentation By Type, Segmentation By Application, Segmentation By End-Use Sector, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Intravenous Fluid Transfer Drug Devices Market

  • 23.1. France Intravenous Fluid Transfer Drug Devices Market, Segmentation By Type, Segmentation By Application, Segmentation By End-Use Sector, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Intravenous Fluid Transfer Drug Devices Market

  • 24.1. Italy Intravenous Fluid Transfer Drug Devices Market, Segmentation By Type, Segmentation By Application, Segmentation By End-Use Sector, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Intravenous Fluid Transfer Drug Devices Market

  • 25.1. Spain Intravenous Fluid Transfer Drug Devices Market, Segmentation By Type, Segmentation By Application, Segmentation By End-Use Sector, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Intravenous Fluid Transfer Drug Devices Market

  • 26.1. Eastern Europe Intravenous Fluid Transfer Drug Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Intravenous Fluid Transfer Drug Devices Market, Segmentation By Type, Segmentation By Application, Segmentation By End-Use Sector, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Intravenous Fluid Transfer Drug Devices Market

  • 27.1. Russia Intravenous Fluid Transfer Drug Devices Market, Segmentation By Type, Segmentation By Application, Segmentation By End-Use Sector, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Intravenous Fluid Transfer Drug Devices Market

  • 28.1. North America Intravenous Fluid Transfer Drug Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Intravenous Fluid Transfer Drug Devices Market, Segmentation By Type, Segmentation By Application, Segmentation By End-Use Sector, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Intravenous Fluid Transfer Drug Devices Market

  • 29.1. USA Intravenous Fluid Transfer Drug Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Intravenous Fluid Transfer Drug Devices Market, Segmentation By Type, Segmentation By Application, Segmentation By End-Use Sector, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Intravenous Fluid Transfer Drug Devices Market

  • 30.1. Canada Intravenous Fluid Transfer Drug Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Intravenous Fluid Transfer Drug Devices Market, Segmentation By Type, Segmentation By Application, Segmentation By End-Use Sector, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Intravenous Fluid Transfer Drug Devices Market

  • 31.1. South America Intravenous Fluid Transfer Drug Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Intravenous Fluid Transfer Drug Devices Market, Segmentation By Type, Segmentation By Application, Segmentation By End-Use Sector, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Intravenous Fluid Transfer Drug Devices Market

  • 32.1. Brazil Intravenous Fluid Transfer Drug Devices Market, Segmentation By Type, Segmentation By Application, Segmentation By End-Use Sector, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Intravenous Fluid Transfer Drug Devices Market

  • 33.1. Middle East Intravenous Fluid Transfer Drug Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Intravenous Fluid Transfer Drug Devices Market, Segmentation By Type, Segmentation By Application, Segmentation By End-Use Sector, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Intravenous Fluid Transfer Drug Devices Market

  • 34.1. Africa Intravenous Fluid Transfer Drug Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Intravenous Fluid Transfer Drug Devices Market, Segmentation By Type, Segmentation By Application, Segmentation By End-Use Sector, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Intravenous Fluid Transfer Drug Devices Market Regulatory and Investment Landscape

36. Intravenous Fluid Transfer Drug Devices Market Competitive Landscape And Company Profiles

  • 36.1. Intravenous Fluid Transfer Drug Devices Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Intravenous Fluid Transfer Drug Devices Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Intravenous Fluid Transfer Drug Devices Market Company Profiles
    • 36.3.1. Cardinal Health Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. B Braun Holding GmbH Co KG Overview, Products and Services, Strategy and Financial Analysis

37. Intravenous Fluid Transfer Drug Devices Market Other Major And Innovative Companies

  • Fresenius Kabi AG, Nipro Corporation, West Pharmaceutical Services Inc., ICU Medical Inc., Merit Medical Systems Inc., Vygon SAS, AngioDynamics Inc., Elcam Medical Inc., InfuSystem Holdings Inc., CODAN US Corporation, Arcomed AG, Terumo Corporation, Smiths Medical, IRadimed Corporation, Micrel Medical Devices SA

38. Global Intravenous Fluid Transfer Drug Devices Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Intravenous Fluid Transfer Drug Devices Market

40. Intravenous Fluid Transfer Drug Devices Market High Potential Countries, Segments and Strategies

  • 40.1 Intravenous Fluid Transfer Drug Devices Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Intravenous Fluid Transfer Drug Devices Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Intravenous Fluid Transfer Drug Devices Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer